JI Lei, LI Zhan-qiang, LU Dian-xiang. Recent advances of HIF-2α in pulmonary hypertensionJ. Acta Pharmaceutica Sinica, 2022,57(2): 277-286. doi: 10.16438/j.0513-4870.2021-0632
Citation: JI Lei, LI Zhan-qiang, LU Dian-xiang. Recent advances of HIF-2α in pulmonary hypertensionJ. Acta Pharmaceutica Sinica, 2022,57(2): 277-286. doi: 10.16438/j.0513-4870.2021-0632

Recent advances of HIF-2α in pulmonary hypertension

  • Pulmonary hypertension (PH) is a kind of disease characterized by progressive increase of pulmonary vascular resistance and occlusive vascular remodeling. Hypoxic inductive factor-2α (HIF-2α) plays an important role in the abnormal proliferation of pulmonary vascular cells and pulmonary vascular remodeling. This review focuses on the role of HIF-2α in pulmonary hypertension at the cellular and the global level, and candidates targeting HIF-2α for the treatment of pulmonary hypertension, in order to better understand the pathogenesis of PH and find effective treatments.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return